April 28, 2021
8:00-9:00 am
Virtual
After registering, you will receive a confirmation email containing information to join the meeting.
Integrated Approach to
Semi-Continuous Biopharmaceutical Manufacturing
Register HERE.
GlaxoSmithKline’s approach to developing a semi-continuous manufacturing platform is to maximize equipment utilization and reduce the capital investment required for future facilities, resulting in a flexible and small manufacturing platform that can support varying BDS manufacturing demands.
Speaker:
Mehdi Ghodbane, PhD,Scientific Leader, Biopharmaceutical Product Development & Supply, GlaxoSmithKline
If you need help attending an event, please contact
president@ispedvc.org, ISPE-DVC may be able to help.